ArticleJournal of pancreatic cancer2021

Cobimetinib Plus Gemcitabine: An Active Combination in KRAS G12R-Mutated Pancreatic Ductal Adenocarcinoma Patients in Previously Treated and Failed Multiple Chemotherapies.

Bach Ardalan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.